Hydroxychloroquine tablets have remained an important pharmaceutical product across global healthcare systems for decades. Originally developed as an antimalarial medicine, Hydroxychloroquine is now widely used in the management of autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus. Due to its broad therapeutic applications and consistent worldwide demand, pharmaceutical companies, government agencies, hospital procurement organizations, and international distributors continue to seek reliable Hydroxychloroquine tablets manufacturers capable of supplying high-quality products with regulatory compliance.
For importers and pharmaceutical businesses, selecting the right manufacturing partner is essential. Quality, manufacturing standards, production capacity, regulatory documentation, and timely delivery directly influence long-term business success.
Wellona Pharma is a trusted Hydroxychloroquine Tablets Manufacturer and Supplier offering WHO-GMP certified manufacturing facilities, international regulatory support, private labeling services, and pharmaceutical exports to more than 86 countries. Our commitment to quality, consistency, and customer satisfaction has established us as a preferred partner for pharmaceutical distributors and healthcare organizations worldwide.
Hydroxychloroquine belongs to the antimalarial drug class and is also classified as a disease-modifying antirheumatic drug (DMARD). Under physician supervision, it is prescribed for several medical conditions depending on local treatment guidelines.
Hydroxychloroquine tablets are commonly used for:
As an established medicine with decades of clinical use, Hydroxychloroquine remains an important product in hospital formularies and pharmaceutical supply chains.
At Wellona Pharma's Tablet Manufacturing Division, Hydroxychloroquine tablets are manufactured using advanced pharmaceutical technology while following stringent WHO-GMP manufacturing practices.
Our manufacturing facility offers:
Every production batch is manufactured according to validated procedures to ensure consistent quality and batch-to-batch uniformity.
Wellona Pharma manufactures Hydroxychloroquine tablets in multiple strengths based on market requirements.
Common strengths include:
Custom packaging and labeling can be developed according to importer specifications and regulatory requirements.
International pharmaceutical buyers increasingly prefer manufacturers operating under WHO-GMP standards because they provide confidence in manufacturing quality and regulatory compliance.
WHO-GMP manufacturing includes:
These systems help ensure pharmaceutical products consistently meet international quality expectations.
Every stage of Hydroxychloroquine tablet manufacturing is carefully monitored to maintain quality and regulatory compliance.
Active Pharmaceutical Ingredients are sourced only from qualified suppliers following strict vendor qualification procedures.
Incoming materials undergo:
Only approved materials proceed to production.
Validated granulation techniques improve powder flow, tablet compression, and dosage consistency.
Modern tablet presses ensure:
Depending on customer requirements, tablets may be supplied as:
Finished products are packed using automated packaging systems under controlled environmental conditions.
Quality remains the foundation of pharmaceutical manufacturing.
Each Hydroxychloroquine tablet batch undergoes extensive testing, including:
Every finished batch is reviewed by qualified quality assurance personnel before release.
Learn more about our Quality Control & Quality Assurance systems.
Different international markets require customized pharmaceutical packaging.
Wellona Pharma offers:
Packaging artwork is customized according to importer branding requirements.
Hydroxychloroquine tablets manufactured by Wellona Pharma are exported to pharmaceutical companies operating across:
Our experienced export team ensures smooth documentation, regulatory compliance, and timely international deliveries.
Successful pharmaceutical exports require complete regulatory documentation.
Wellona Pharma provides:
These documents assist customers with product registration in their respective countries.
Many pharmaceutical companies prefer outsourcing production to experienced WHO-GMP manufacturers.
Our Contract Manufacturing and Third Party Manufacturing services include:
This enables distributors and pharmaceutical companies to expand their product portfolios without investing in manufacturing infrastructure.
International buyers trust Wellona Pharma because of our commitment to manufacturing excellence.
Our strengths include:
These advantages make us a dependable pharmaceutical manufacturing partner.
Although prescribing practices differ across countries, Hydroxychloroquine continues to be an important medicine in several therapeutic areas. Healthcare institutions maintain demand through:
Reliable manufacturers with consistent production capabilities continue to play an important role in supporting healthcare systems worldwide.
Regulatory compliance is critical for pharmaceutical exports.
Our manufacturing follows internationally accepted quality systems to support registration in regulated and semi-regulated markets.
Buyers benefit from:
Additional information regarding Good Manufacturing Practices is available from the World Health Organization (WHO).
Successful pharmaceutical businesses depend on manufacturers capable of delivering consistent quality over many years.
At Wellona Pharma, we focus on building long-term partnerships through:
Whether supplying distributors, hospital procurement organizations, government agencies, or pharmaceutical companies, our goal is to provide dependable manufacturing solutions that support sustainable business growth.
Yes. We manufacture Hydroxychloroquine tablets in commonly required strengths, including 200 mg, depending on customer and market requirements.
Yes. Our manufacturing facilities operate under WHO-GMP standards with comprehensive quality assurance systems.
Absolutely. We offer OEM manufacturing, private labeling, customized packaging, and branding solutions for international pharmaceutical companies.
We export to more than 86 countries across Africa, Asia, the Middle East, CIS nations, Latin America, and several other international markets.
We provide COA, COPP, CTD/ACTD dossiers, stability data, Free Sale Certificate, Batch Manufacturing Records, MSDS, and other documentation required for product registration.
If you are looking for a trusted Hydroxychloroquine Tablets Manufacturer and Supplier with WHO-GMP certified manufacturing, global export expertise, and comprehensive regulatory support, Wellona Pharma is your reliable pharmaceutical partner.
Explore our Tablet Product Category to discover our complete tablet portfolio, or contact our team today to discuss bulk procurement, contract manufacturing, third-party manufacturing, private labeling, and international pharmaceutical export opportunities.